Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Jun 19, 2024 11:46am
RE:RE:RE:RE:RE:Question: Once LABS has 4 or 5 approved drugs, can they
The MD&A is clear on which clinical trials LABS is associated with and none are 'late-stage' and the amount does not total 20. But I agree fully that they need to provide shareholders an
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Jun 19, 2024 10:24am
RE:RE:RE:RE:Question: Once LABS has 4 or 5 approved drugs, can they
QC1, it would be nice if Medipharm would expand on the following statement they made recently and in particular the IND's. "MediPharm has been referenced in FDA Investigational New Drug
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Jun 19, 2024 10:07am
RE:Elmer Fudd, where is the LABS press release? You are
piduks, there is no doubt Labs can do a much better job in the promo dept. as I was under the impression AVCN and LABS were working together on the SEDDS technology. Has this relationship changed
...more
(45)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jun 19, 2024 8:38am
Elmer Fudd, where is the LABS press release? You are
useless because Medpharm Labs has a deal with Avicanna to use this technology as well and this patent has a material impact of Medipharm as well. Elmer, ever hear the saying about udders
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Jun 19, 2024 8:37am
“Preparing for generic epidiolex”..Padagis US LLC..
According to Jazz’s filings, in October 2023, it settled with Padagis US LLC and granted Padagis a license to manufacture, market, and sell its generic version of Epidiolex on a date that depends on
...more
(45)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jun 19, 2024 8:33am
5 new drugs and exclusive rights sale + royalties
ANVISA x 2, 505(b)2, NDA, generic Epidiolex, Medipharm is under no obligation to supply their FDA approved API for generic Epidiolex to any pharma company that approaches and can sell the rights to
...more
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Jun 19, 2024 6:59am
RE:RE:RE:Question: Once LABS has 4 or 5 approved drugs, can they
LABS is a long way from any 'new drug'. Closest they are is with Epidiolex and even that is looking ever more unlikely in the short term given the recent ruling in the US against one (or
...more
(100)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Jun 18, 2024 11:08pm
RE:RE:Question: Once LABS has 4 or 5 approved drugs, can they
That's more or less how I imagine it too That Medipharm Labs gets the rights/licenses to produce these new drugs and pays a license fee.
(45)
•••
piduks
X
View Profile
View Bullboard History
Comment by
piduks
on Jun 18, 2024 7:08pm
RE:Question: Once LABS has 4 or 5 approved drugs, can they
jump into the Chevy, heading for big lights, want to know the rest? Hey...BUY THE RIGHTS.
(45)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jun 18, 2024 7:00pm
Question: Once LABS has 4 or 5 approved drugs, can they
SELL the rights to those drugs to larger pharmaceutical companies along with a small royalty structure?
(47)
•••
Romulus22
X
View Profile
View Bullboard History
Comment by
Romulus22
on Jun 18, 2024 4:10pm
RE:RE:RE:RE:If Medipharm continues to improve QOQ
Well Said! I have been a long term shareholder that has averaged down to .30 after all this time. I'll be damned if mgt pulls something that shafts its shareholders. They haven't shown regard
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Jun 18, 2024 2:57pm
Cannafarms, Vivo, medipharm.
The closure of the longest running, first approved cultivation facility in British Columbia is mentioned through one sentence on a CC!...are you kidding...nothing on the plans, or future of this
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Jun 18, 2024 2:45pm
Current valuation
Is completely ridiculous, B O D needs to support a normal course issuer bid(share buyback filing) and start accumulating shares for cancellation...volume is very low, it wouldn't take much from
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Jun 18, 2024 2:39pm
RE:RE:If Medipharm continues to improve QOQ
and therein lies the conundrum for shareholders QC1 Management has publicly stated they believe the current market cap of Medipharm is very undervalued, yet short of quarterly required disclosure
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >